This article was written by Follow Alberto holds a Master’s degree in Business Economics. During his academic career he acquired an extensive managerial and...
This article was written by Follow As a tech-focused industry Research Analyst, I aim to provide differentiated insights, whether it is for investing, trading,...
This article was written by Follow Full time trader and investor. Instead of lengthy and boring articles, I prefer writing concise arguments about value...
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
This article is reprinted by permission from NerdWallet. With layoffs, bank closures and inflation, financial tensions remain high for many Americans heading into the...
Alibaba Group Holding Limited (NYSE:BABA) just released its March quarter earnings and easily beat consensus expectations. The release beat analyst expectations on revenue as...
Skipping the 2023 model year entirely, the 2024 Chevrolet Trax roars back onto the subcompact SUV stage, totally redesigned inside and out. Longer and...
Background Apellis Pharmaceuticals (NASDAQ:APLS), is a US-based commercial biotech focused on innovative biologics that inhibit the complement system via C3 targeting. The firm’s innovative...
The video version of this article was published on Dividend Kings on Tuesday, May 16th. ————————————————————————————— Midstream investors remember the dark days following the...
Investment Thesis Despite the stagnant smoking tobacco market, Altria Group (NYSE:MO) remains a stable company. Altria shifts inflation to consumers, which partially compensates for...